APA (7th ed.) Citation

Hamada, K., Isobe, J., Hattori, K., Hosonuma, M., Baba, Y., Murayama, M., . . . Yoshimura, K. (2023). Turicibacter and Acidaminococcus predict immune-related adverse events and efficacy of immune checkpoint inhibitor. Frontiers in Immunology, 14, . https://doi.org/10.3389/fimmu.2023.1164724

Chicago Style (17th ed.) Citation

Hamada, Kazuyuki, et al. "Turicibacter and Acidaminococcus Predict Immune-related Adverse Events and Efficacy of Immune Checkpoint Inhibitor." Frontiers in Immunology 14 (2023). https://doi.org/10.3389/fimmu.2023.1164724.

MLA (9th ed.) Citation

Hamada, Kazuyuki, et al. "Turicibacter and Acidaminococcus Predict Immune-related Adverse Events and Efficacy of Immune Checkpoint Inhibitor." Frontiers in Immunology, vol. 14, 2023, https://doi.org/10.3389/fimmu.2023.1164724.